MCP-1 is one of the novel inflammatory biomarkers in obese patients, and it is upregulated in genetic obesity and diet-induced obesity, but only a few studies have addressed the expression of MCP-1 in the VAT of obese humans [12, 35, 36]. The gene discussed is CCL2; the disease is obesity disorder.